Business Insider16d
New Findings Show how LIXTE’s Lead Clinical Compound, LB-100, is Metabolized to its Active Form
As published in BioXriv, scientists at the Netherlands Cancer Institute have discovered an enzyme that mediates the conversion of LB-100 into the active metabolite endothall. Accordingly, this protein ...
Business Insider16d
Lixte announces online publication of new pre-clinical data in BioXriv
As published in BioXriv, scientists at the Netherlands Cancer Institute have discovered an enzyme that mediates the conversion of LB-100 into the active metabolite endothall. Accordingly ...
Morningstar16d
New Findings Show how LIXTE’s Lead Clinical Compound, LB-100, is Metabolized to its Active Form
As published in BioXriv, scientists at the Netherlands Cancer Institute have discovered an enzyme that mediates the conversion of LB-100 into the active metabolite endothall. Accordingly ...